Mutations in the EGFR gene are one type of biomarker associated with lungcancer. Advances in the understanding of biomarkers means treatment can now be targeted to characteristics of a patients cancer. SciencefromAtoZ ASCO19 LCSMpic.twitter.comWJ

Mutations in the EGFR gene are one type of biomarker associated with #lungcancer. Advances in the understanding of biomarkers means treatment can now be targeted to characteristics of a patient’s #cancer. #SciencefromAtoZ #ASCO19 #LCSMpic.twitter.com/WJ

14:14 EDT 1 Jun 2019 | AztraZeneca

Mutations in the EGFR gene are one type of biomarker associated with #lungcancer. Advances in the understanding of biomarkers means treatment can now be targeted to characteristics of a patient’s #cancer. #SciencefromAtoZ #ASCO19 #LCSM pic.twitter.com/WJClyP4sx9

More From BioPortfolio on "Mutations in the EGFR gene are one type of biomarker associated with #lungcancer. Advances in the understanding of biomarkers means treatment can now be targeted to characteristics of a patient’s #cancer. #SciencefromAtoZ #ASCO19 #LCSMpic.twitter.com/WJ"